Sumycin: Effective Tetracycline Antibiotic for Bacterial Infections
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.31 | $56.23 (0%) | 🛒 Add to cart |
| 360 | $0.27
Best per pill | $112.45 $97.39 (13%) | 🛒 Add to cart |
Similar products
Sumycin is a prescription antibiotic medication containing the active ingredient tetracycline hydrochloride. It belongs to the tetracycline class of antibiotics and is indicated for the treatment of a wide spectrum of bacterial infections. This bacteriostatic agent works by inhibiting protein synthesis in susceptible bacteria, thereby stopping their growth and proliferation. Sumycin is particularly valued in clinical practice for its efficacy against both gram-positive and gram-negative organisms, as well as certain atypical pathogens. Proper use under medical supervision ensures optimal therapeutic outcomes while minimizing risks.
Features
- Active ingredient: Tetracycline hydrochloride 250 mg or 500 mg per capsule
- Formulation: Hard gelatin capsules for oral administration
- Mechanism: Bacteriostatic inhibition of bacterial protein synthesis
- Spectrum: Broad activity against gram-positive and gram-negative bacteria
- Manufacturer: Standard pharmaceutical grade production under cGMP
- Packaging: Bottles of 100 capsules with child-resistant closure
- Stability: Shelf-stable formulation with proper storage
Benefits
- Effectively treats respiratory infections including pneumonia and bronchitis
- Clears acne vulgaris and rosacea through anti-inflammatory and antibacterial action
- Manages sexually transmitted infections like chlamydia and gonorrhea
- Controls tick-borne illnesses including Lyme disease and Rocky Mountain spotted fever
- Addresses urinary tract infections caused by susceptible organisms
- Prevents malaria when used as prophylactic treatment in endemic areas
Common use
Sumycin is commonly prescribed for bacterial infections including respiratory tract infections (such as pneumonia, bronchitis, and pertussis), urinary tract infections, skin and soft tissue infections (including acne vulgaris), sexually transmitted infections (particularly chlamydia, gonorrhea, and syphilis), tick-borne diseases (Lyme disease, Rocky Mountain spotted fever), and certain gastrointestinal infections. It is also used as prophylactic treatment for malaria in travelers to endemic regions and for the management of anthrax exposure. The medication may be prescribed for other off-label uses as determined appropriate by healthcare providers based on susceptibility testing and clinical judgment.
Dosage and direction
The dosage of Sumycin must be individualized based on the type and severity of infection, patient’s age, renal function, and susceptibility of the causative organisms. For adults, the usual dosage is 500 mg twice daily or 250 mg four times daily. For more severe infections, an initial dose of 500 mg four times daily may be required. Pediatric dosing (above 8 years of age) is typically 25-50 mg/kg/day divided into four equal doses. Administer Sumycin capsules with a full glass of water at least one hour before or two hours after meals. Do not take with dairy products, antacids, or iron supplements as these significantly reduce absorption. Complete the full prescribed course even if symptoms improve earlier to prevent antibiotic resistance. Dosage adjustments are necessary for patients with renal impairment.
Precautions
Patients should inform their healthcare provider about any history of kidney disease, liver impairment, or systemic lupus erythematosus. Sumycin may cause photosensitivity reactions; avoid excessive sunlight exposure and use protective measures including clothing and sunscreen. This antibiotic may decrease the effectiveness of oral contraceptives; additional non-hormonal contraception is recommended during treatment. Use with caution in patients with a history of gastrointestinal diseases, particularly colitis. Prolonged use may result in fungal or bacterial superinfection, including pseudomembranous colitis. Dental discoloration and enamel hypoplasia may occur if used during tooth development (last half of pregnancy, infancy, and childhood up to 8 years). Regular monitoring of renal, hepatic, and hematopoietic function is advised during prolonged therapy.
Contraindications
Sumycin is contraindicated in patients with known hypersensitivity to tetracycline or any component of the formulation. It should not be used during pregnancy due to risk of fetal harm including inhibition of bone growth and permanent tooth discoloration. Contraindicated in children under 8 years of age due to risk of permanent tooth discoloration and enamel hypoplasia. Avoid use in patients with severe hepatic impairment or those taking isotretinoin concurrently. Do not administer to patients with systemic lupus erythematosus as tetracyclines may exacerbate this condition. Concomitant use with penicillin antibiotics is contraindicated due to antagonistic effects.
Possible side effect
Common side effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, epigastric distress, and glossitis. Dermatological reactions may include photosensitivity, rash, and onycholysis. Less frequently reported effects include esophageal ulceration, stomatitis, black hairy tongue, and enterocolitis. Rare but serious adverse reactions include pseudotumor cerebri (benign intracranial hypertension), hepatotoxicity, pancreatitis, and blood dyscrasias. Hypersensitivity reactions ranging from urticaria to anaphylaxis may occur. Prolonged use may lead to superinfection with resistant organisms or candidiasis. Discoloration of teeth and inhibition of bone growth may occur if used during tooth development or pregnancy.
Drug interaction
Sumycin interacts significantly with antacids containing aluminum, calcium, or magnesium; iron preparations; and zinc salts, which markedly reduce absorption. Concurrent administration with oral contraceptives may decrease contraceptive efficacy. Warfarin effects may be potentiated, requiring close monitoring of prothrombin time. Concurrent use with methoxyflurane may result in fatal renal toxicity. Isotretinoin coadministration may increase the risk of pseudotumor cerebri. Penicillin antibiotics may have reduced efficacy when given with tetracyclines. Sumycin may decrease the efficacy of bactericidal antibiotics and increase the toxicity of digoxin through alteration of gut flora. Administration with retinoids may potentiate intracranial hypertension.
Missed dose
If a dose of Sumycin is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the regular dosing schedule. Do not double the dose to make up for a missed one. Maintaining consistent blood levels is important for antibiotic efficacy, but occasional missed doses are generally not problematic if the overall treatment course is completed. If multiple doses are missed or uncertainty exists about proper dosing, consult the prescribing healthcare provider for guidance.
Overdose
Overdosage of Sumycin may manifest as nausea, vomiting, and diarrhea. In severe cases, pancreatitis and hepatic toxicity may occur. No specific antidote exists. Management involves immediate gastric lavage if ingestion was recent, followed by supportive and symptomatic treatment. Hemodialysis does not significantly remove tetracycline from circulation. Maintain adequate hydration and electrolyte balance. Monitor renal and hepatic function closely. Symptomatic treatment for gastrointestinal distress may include antiemetics and fluid replacement. In cases of significant overdose, seek immediate medical attention or contact a poison control center.
Storage
Store Sumycin capsules at controlled room temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). Keep in the original container with the lid tightly closed to protect from moisture and light. Do not store in bathroom cabinets where humidity levels fluctuate. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly discard any unused medication after completing the treatment course or if the medication has expired. Do not flush medications down the toilet or pour into drains unless instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Sumycin is a prescription medication that should only be used under the supervision of a qualified healthcare professional. The content presented does not cover all possible uses, directions, precautions, or adverse effects. Always consult with a physician or pharmacist for personalized medical advice. Do not disregard professional medical advice or delay seeking it because of information contained herein. Individual results may vary based on specific health conditions and adherence to prescribed treatment.
Reviews
Clinical studies demonstrate Sumycin’s efficacy with approximately 85-90% success rates in treating susceptible bacterial infections when used appropriately. Dermatologists report significant improvement in inflammatory acne lesions within 8-12 weeks of treatment. Infectious disease specialists note its reliable activity against atypical pathogens and value in resource-limited settings. Some patients report gastrointestinal discomfort as the most common treatment-limiting factor. Overall professional assessment considers Sumycin a valuable antibiotic option when susceptibility is confirmed and contraindications are observed. Patient satisfaction surveys indicate good tolerance when taken properly with adequate hydration and food avoidance recommendations followed.